MIR6771

Across TCGA pan-cancer cohorts, MIR6771 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR6771 data layer.

The strongest signal is observed in thymoma (THYM), where higher MIR6771 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6771 expression acts as an unfavorable survival marker.

THYM, HNSC, and READ are the cancer types where MIR6771 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.039	0.928	<.001	48	view →
HNSC	OS	Tertile	All	0.379	0.772	.002	36	view →
READ	DFS	Tertile	All	0.162	0.720	.019	36	view →
LUAD	OS	Tertile	III,IV	0.163	0.663	.012	36	view →
KIRC	OS	Tertile	All	0.354	0.633	.009	24	view →
LGG	OS	Tertile	All	0.142	0.909	<.001	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
UCEC	OS	Tertile	All	0.826	0.929	.026	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR6771–THYM (OS)

Open the THYM breakdown →